Mode
Text Size
Log in / Sign up
Phase 3 Completed N=18 Randomized Treatment

Buprenorphine Group Medical Visits in Primary Care

Opioid-Related Disorders
Source: ClinicalTrials.gov NCT02526212 ↗
Enrolled (actual)
18
Serious AEs
0.0%
Results posted
Jul 2020
Primary outcomePrimary: Number of Participants With Opioid Abstinence at 8 Weeks — 0; 1 Participants — p=0.44
◆ Published Evidence
No publication linked

No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.

Summary

The primary goal of this research is to improve the effectiveness of buprenorphine maintenance treatment (BMT) within primary care. Investigators propose that providing BMT as part of a group medical visit (instead of an individual visit) will improve treatment outcomes for patients with persistent opioid abuse, because members become accountable to the group, are exposed to beneficial habits of others (i.e. positive deviance), and can receive efficacious behavioral interventions concomitantly with medical management

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Opioid Abstinence at 8 Weeks
0; 1 0.44
SECONDARY
Number of Participants Who Were Retained in Buprenorphine Treatment at 3 Months and 6 Months
8; 7; 8; 6
SECONDARY
Number of Participants Who Reported Sharing Injection Equipment at 8 Weeks
0; 0
SECONDARY
Acceptability (Scale)
4.6; 4.8 0.20
SECONDARY
Feasibility (Percentage of Visits Attended)
69; 71

Eligibility Criteria

Inclusion Criteria

  • Currently receiving BMT at Montefiore community health center (CHC).
  • Received BMT for 12 or more weeks.
  • Persistent opioid abuse (positive toxicology for an unprescribed opioid at most recent test or in 50% or more of collected tests in the previous 6 months.)
  • Fluent in English of Spanish

Exclusion Criteria

  • Pregnancy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02526212). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search